View in EDS

EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective.

Saved in:
Bibliographic Details
Title: EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective.
Authors: Parackal, A1 (AUTHOR), Ting, E2 (AUTHOR), Verhoek, A3 (AUTHOR), Joy, A4 (AUTHOR), Sehdev, S5 (AUTHOR), Hettle, R6 (AUTHOR)
Source: Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS115-S116. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 177910745
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Parackal%2C+A%22">Parackal, A</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ting%2C+E%22">Ting, E</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verhoek%2C+A%22">Verhoek, A</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Joy%2C+A%22">Joy, A</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sehdev%2C+S%22">Sehdev, S</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hettle%2C+R%22">Hettle, R</searchLink><relatesTo>6</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Value+in+Health%22">Value in Health</searchLink>. 2024 Supplement, Vol. 27 Issue 6, pS115-S116. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=177910745
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jval.2024.03.616
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S115
    Titles:
      – TitleFull: EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Parackal, A
      – PersonEntity:
          Name:
            NameFull: Ting, E
      – PersonEntity:
          Name:
            NameFull: Verhoek, A
      – PersonEntity:
          Name:
            NameFull: Joy, A
      – PersonEntity:
          Name:
            NameFull: Sehdev, S
      – PersonEntity:
          Name:
            NameFull: Hettle, R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 06
              Text: 2024 Supplement
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 10983015
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Value in Health
              Type: main
ResultId 1